You have 9 free searches left this month | for more free features.

GDC0941

Showing 1 - 18 of 18

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Solid Tumours, Breast Cancer Trial in London, Manchester (Palbociclib + Taselisib / Pictilisib)

Unknown status
  • Advanced Solid Tumours
  • Breast Cancer
  • Palbociclib + Taselisib / Pictilisib
  • London, United Kingdom
  • +1 more
Nov 15, 2019

Acute Myeloid Leukemia Trial in Houston (Azacitidine, Venetoclax, NK Cells)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    M.D. Anderson Cancer Center
Apr 17, 2023

HER2-positive Breast Cancer, Metastatic Breast Cancer Trial in Seoul (Trastuzumab biosimilars(Herzuma), Gedatolisib)

Unknown status
  • HER2-positive Breast Cancer
  • Metastatic Breast Cancer
  • Trastuzumab biosimilars(Herzuma), Gedatolisib
  • Seoul, Korea, Republic of
    Samsung Medical Center
Feb 16, 2021

Healthy Volunteer Trial in Austin (GDC-0941, ketoconazole)

Completed
  • Healthy Volunteer
  • Austin, Texas
    Investigational Site
Mar 2, 2017

Estrogen Receptor Negative Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Triple Negative Breast

Terminated
  • Estrogen Receptor Negative Breast Cancer
  • +5 more
  • Birmingham, Alabama
  • +15 more
May 22, 2017

Healthy Volunteers Trial in South San Francisco (GDC-0941, rabeprazole)

Completed
  • Healthy Volunteers
  • South San Francisco, California
    Genentech Trial Information Support
Feb 7, 2017

Healthy Volunteer Trial in Madison (GDC-0941)

Completed
  • Healthy Volunteer
  • Madison, Wisconsin
    (unnamed)
Nov 1, 2016

Solid Tumors Trial in United States (Cobimetinib, Pictilisib)

Terminated
  • Solid Tumors
  • Baltimore, Maryland
  • +5 more
Nov 4, 2016

Breast Cancer Trial in Belgium, Italy, United States (Bevacizumab, Pictilisib, Letrozole)

Completed
  • Breast Cancer
  • Peoria, Illinois
  • +4 more
Dec 14, 2016

Healthy Volunteer Trial in Madison (GDC-0941)

Completed
  • Healthy Volunteer
  • Madison, Wisconsin
    (unnamed)
Nov 1, 2016

Non-Squamous NSCLC, Solid Cancers Trial in Netherlands, United States (GDC-0941, erlotinib HCl)

Completed
  • Non-Squamous Non-Small Cell Lung Cancer, Solid Cancers
  • Aurora, Colorado
  • +3 more
Nov 1, 2016

Solid Cancers Trial in Scottsdale, Boston, Detroit (GDC-0941)

Completed
  • Solid Cancers
  • Scottsdale, Arizona
  • +2 more
Nov 1, 2016

Non-Hodgkin's Lymphoma, Solid Cancers Trial in Sutton (GDC-0941)

Completed
  • Non-Hodgkin's Lymphoma, Solid Cancers
  • Sutton, United Kingdom
    (unnamed)
Nov 1, 2016

Metastatic Breast Cancer Trial in Indianapolis, Baltimore, Boston (GDC-0941, Trastuzumab, trastuzumab-MCC-DM1)

Completed
  • Metastatic Breast Cancer
  • Indianapolis, Indiana
  • +2 more
Nov 1, 2016

Non-Squamous NSCLC Trial in Buffalo, Villejuif, Groningen (GDC-0941, bevacizumab, carboplatin)

Completed
  • Non-Squamous Non-Small Cell Lung Cancer
  • Buffalo, New York
  • +2 more
Nov 1, 2016

Breast Cancer Trial in Worldwide (Fulvestrant, GDC-0941, GDC-0941 Matching Placebo)

Completed
  • Breast Cancer
  • Birmingham, Alabama
  • +129 more
Nov 1, 2016

Breast Cancer Trial in Worldwide (GDC-0941, Placebo, Paclitaxel)

Completed
  • Breast Cancer
  • Sedona, Arizona
  • +96 more
Apr 21, 2017

NSCLC Trial in Worldwide (pictilisib, Placebo, bevacizumab)

Completed
  • Non-Small Cell Lung Cancer
  • Birmingham, Alabama
  • +119 more
Apr 21, 2017